Диссертация (1139785), страница 27
Текст из файла (страница 27)
2003.362 (9386):777–781.224. Yusuf S, Sleight P, Pogue J et al. / Effects of an angiotensin-converting-enzymeinhibitor, ramipril, on cardiovascular events in highrisk patients. The Heart OutcomesPrevention Evaluation Study Investigators // N Engl J Med. 2000.342 (3):145–153.225. Zannad F, Alla F, Dousset B et al. / Limitation of excessive extracellular matrixturnover may contribute to survival benefit of spironolactone therapy in patients withcongestive heart failure. Insights from Randomized Aldactone Evaluation Study(RALES) // Circulation. 2000.102 (22):2700–2706.226.Zannad F, Chati Z, Guest M et al.
/ Differential effect of fosinopril end enalapril inpatients with mild to moderate CHF // Am Heart J. 1998.136 (4 Pt 1):672–680.227. Zannad F, McMurray JJ, Krum H et al. / Eplerenone in patients with systolic heartfailure and mild symptoms // N Engl J Med. 2011;364 (1):11–21.228. Zelis R, Nellis SH, Longhurst J et al. / Abnormalities in the regional circulationsaccompanying congestive heart failure // Prog Cardiovasc Dis.
1975 Nov-Dec.18(3):181-99.144229. Ziff OJ, Lane DA, Samra M, et al. / Safety and efficacy of digoxin: systematicreview and meta-analysis of observational and controlled trial data // BMJ2015.351:h4451.230. Zuber R, Anzenbacherová E, Anzenbacher P / Cytochromes P450 andexperimental models of drug metabolism // J Cell Mol Med 2000. 6:189–198.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
